Category stocks

Alphabet's five-year price target reaches $883–$1,097, driven by cloud growth and AI demand, though capex-driven margin compression and regulatory risks pose near-term headwinds.

The S&P 500's dramatic 35% repricing has exposed genuine bargain equities trading at compelling valuations in early 2026.

Two AI ETFs returned 119% and 42% in 2026, outpacing individual stock picks through diversification and reduced research burden.

Argan's S&P SmallCap 600 inclusion triggered mechanical buying and 12.6% gains, but the real story is whether a $2.9 billion backlog justifies current valuations.

Two dividend aristocrats and one struggling Dividend King offer contrasting lessons about yields and total returns in 2026's market.

Sumitomo Metal Mining's July 3 stock surge reflects gold's rebound and a near-doubling of profit guidance on elevated metal prices.

AlzeCure Pharma stock surged 365% in mid-2026 following two major pharmaceutical partnerships worth over $3 billion.

Stock market gains reach their highest in six years, but hidden warning signs suggest caution for the remainder of 2026.

After a 193% surge fueled by AI hype, Corning faced reckoning as insiders sold and reality caught up with a 14% plunge.